Breaking News

Takeda Selects PRA as Primary Strategic Partner

PRA will use internal resources and services to manage Takeda's pipeline studies across Phases I-IV

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PRA Health Sciences and Takeda Pharmaceutical Co. have entered into a new partnership agreement under which PRA will serve as Takeda’s primary strategic partner for the company’s pipeline and marketed products clinical development and post-approval needs.   The partnership operating model combines operational expertise, transferred from Takeda to PRA, with PRA’s range of global capabilities. This model aims to improve operating efficiencies, drive globalization and reduce fixed infrastructure ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters